Article with in-depth details appears to the left.
Allow 15 seconds for video to load.
For FULL-SCREEN-VIEW, click the icon in the lower right corner of video.
Article
(The video to the right provides broad overviews and opinions. The article below provides in-depth details.)
An independent review has found that an estimated 150, 000 people with dementia in the UK are being inappropriately prescribed antipsychotic drugs.
These are contributing to 1,800 deaths a year.
Antipsychotics have a serious number of side-effects for people with dementia and a profound effect on people's quality of life, leaving them heavily sedated.
They double the risk of death, triple the risk of stroke and accelerate cognitive decline. Care Services Minister announced a new action plan to tackle the issue.
Alzheimer's Society comment
Simple attention to daily care and an understanding of people's lives can make all the difference in whether or not antipsychotics are needed.
'This, long awaited, landmark review is a welcome recognition of the scale of the issue and Alzheimer's Society's view that these drugs should only ever be used as a last resort. The scandalous over prescription of antipsychotic drugs leads to an estimated 1,800 deaths a year, it must end.
The report suggests prescriptions could be reduced by two thirds in three years, this is vital and the new action plan cannot afford to fail. Change will only be achieved with commitment from government, PCTs and health professionals and clear local targets. Almost 150,000 people are being inappropriately prescribed these drugs as a chemical restraint . Today must mark a change in dementia care.'
Facts on Antipsychotics
- Antipsychotic drugs are effective treatments for people with schizophrenia, but have become widely used to treat behavioural symptoms such as aggression, agitation and restlessness in people with dementia. The drugs are used off- license for people with dementia.
- Antipsychotics have serious number of side-effects for people with dementia and a profound effect on people's quality of life, leaving them heavily sedated. They double the risk of death, triple the risk of stroke and accelerate cognitive decline. People are at increased risk of parkinsonism, chest infections and fluid retention.
- Alzheimer's Society research has shown that training and support for care home staff reduces the need to use antipsychotics in residents with dementia and can be a viable alternative for managing challenging behaviour.
- Antipsychotic prescriptions to people with dementia cost the UK £60 million per annum. Alzheimer's Society research shows that person centred care can reduce these costs by half saving £30 million a year.
- Alzheimer's Society research found that 77 per cent of nurses report that antipsychotic drugs are often used to treat people with dementia in the hospital environment . A quarter of these nurses said antipsychotics were used inappropriately
- Over half of people with dementia will experience psychiatric symptoms and/or challenging behaviour at some stage of their condition (Ballard, Waite and Birks, 2006). These symptoms may occur because of pain, physical illness, anxiety, unmet needs or as a response to a confusing environment (All Party Parliamentary Group on Dementia, 2008).
Welcome News
Commenting on the announcement of a Government action plan to tackle the over prescribing of antipsychotic drugs to people with dementia, Dr. Peter Carter, Royal College of Nursing's Chief Executive & General Secretary said:
"It is welcome news that the Government has made a commitment to deal with the overuse of anti-psychotic drugs. We look forward to working with the new National Clinical Director for Dementia on these ambitious proposals which offer hope for patients with dementia and their families.
"Dementia, in the absence of a cure, will affect increasing numbers of people in the coming years. To ensure these patients receive the best possible care, it is vital that all health and social care staff working with dementia patients receive appropriate specialist training."
New research into antipsychotic drugs commonly prescribed to Alzheimer's patients concludes that the medication nearly doubles risk of death over 3 years. Guidelines recommend only using them for short periods of time.
A new Alzheimer's-related FDA warning will appear on labels of antipsychotic drugs. It will say that clinical studies indicate that antipsychotic drugs are associated with an increased risk of death when used in elderly patients treated for dementia-related psychosis.
In a recent study, Celexa worked as well as harsh antipsychotics in patients with Alzheimer's disease to reduce agitation, hallucinations and delusions, while having fewer side effects.
In a recent study, Celexa worked as well as harsh antipsychotics in patients with Alzheimer's disease to reduce agitation, hallucinations and delusions, while having fewer side effects.